Olivares Elodie, Badel-Berchoux Stéphanie, Provot Christian, Prévost Gilles, Bernardi Thierry, Jehl François
University of Strasbourg, CHRU Strasbourg, Fédération de Médecine Translationnelle de Strasbourg, EA7290, Institut de Bactériologie, Strasbourg, France.
BioFilm Pharma SAS, Saint-Beauzire, France.
Front Microbiol. 2020 Jan 9;10:2894. doi: 10.3389/fmicb.2019.02894. eCollection 2019.
Bacterial biofilms are highly recalcitrant to antibiotic therapies due to multiple tolerance mechanisms. The involvement of in a wide range of biofilm-related infections often leads to treatment failures. Indeed, few current antimicrobial molecules are still effective on tolerant sessile cells. In contrast, studies increasingly showed that conventional antibiotics can, at low concentrations, induce a phenotype change in bacteria and consequently, the biofilm formation. Understanding the clinical effects of antimicrobials on biofilm establishment is essential to avoid the use of inappropriate treatments in the case of biofilm infections. This article reviews the current knowledge about bacterial growth within a biofilm and the preventive or inducer impact of standard antimicrobials on its formation by . The effect of antibiotics used to treat biofilms of other bacterial species, as or , was also briefly mentioned. Finally, it describes two devices which could potentially be used as antibiotic susceptibility testing for adherent bacteria.
由于多种耐受机制,细菌生物膜对抗生素治疗具有高度抗性。其在广泛的生物膜相关感染中的存在常常导致治疗失败。事实上,目前很少有抗菌分子对耐受的固着细胞仍然有效。相比之下,越来越多的研究表明,传统抗生素在低浓度下可以诱导细菌的表型变化,从而导致生物膜形成。了解抗菌药物对生物膜形成的临床影响对于避免在生物膜感染情况下使用不适当的治疗方法至关重要。本文综述了关于生物膜内细菌生长以及标准抗菌药物对其形成的预防或诱导作用的当前知识。还简要提及了用于治疗其他细菌物种(如 或 )生物膜的抗生素的作用。最后,它描述了两种可能用作粘附细菌抗生素敏感性测试的 装置。